These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 678041)

  • 41. [Persistent extrapyramidal syndrome in neuroleptic therapy].
    Hoff H; Hofmann G
    Wien Med Wochenschr; 1967 Jan; 117(1):14-7. PubMed ID: 6031954
    [No Abstract]   [Full Text] [Related]  

  • 42. [Tardive dyskinesia. Synthetic-critical review and case contribution].
    Campanini T; Catalano A; De Risio C; Forino V
    Ateneo Parmense Acta Biomed; 1977; 48(1):41-60. PubMed ID: 324489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Choreiform syndromes and durable or irreversible hyperkinesias after prolonged treatment with neuroleptic drugs].
    Bergouignan M; Fontanges X; Clèdes J
    Ann Med Psychol (Paris); 1966 Jul; 124(2):186-96. PubMed ID: 5967653
    [No Abstract]   [Full Text] [Related]  

  • 44. [Indications for lithium salts in psychiatric therapeutics].
    Deniker P; Ginestet D; Lôo H; Colonna L
    Nouv Presse Med; 1972 Dec; 1(44):2959-62. PubMed ID: 4660967
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapeutic problems with psychotropic drugs: some epidemiological considerations.
    Shepherd M
    Psychiatr Neurol Neurochir; 1969; 72(6):503-6. PubMed ID: 5369241
    [No Abstract]   [Full Text] [Related]  

  • 46. [Indications and results in the use of 19.552 RP].
    López-Ibor Aliño JM; López-Ibor Aliño JJ
    Actas Luso Esp Neurol Psiquiatr; 1971; 30(1):17-28. PubMed ID: 4945618
    [No Abstract]   [Full Text] [Related]  

  • 47. [Ocular and cutaneous changes in patients exposed to prolonged treatment with neuroleptic drugs].
    Francesconi G; Di Tizio A; Cameo D
    Ann Ottalmol Clin Ocul; 1968 Jul; 94(7):835-52. PubMed ID: 4236709
    [No Abstract]   [Full Text] [Related]  

  • 48. Antipsychotic, antianxiety, and antidepressant drugs.
    Caffey EM; Hollister LE; Kaim SC; Pokorny AD
    Med Bull Vet Adm; 1966 Sep; 11():1-23. PubMed ID: 5927811
    [No Abstract]   [Full Text] [Related]  

  • 49. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
    Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
    Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Use of diazepam in psychiatric practice].
    Aleksandrovskiĭ IuA; Prokudin VN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(8):1231-7. PubMed ID: 5705720
    [No Abstract]   [Full Text] [Related]  

  • 51. [Dolichomegacolon caused by neuroleptic drugs in a psychiatric environment (apropos of 153 cases)].
    Bourgeois M; Lefort H; Legros P
    Ann Med Psychol (Paris); 1972 Apr; 1(4):556-66. PubMed ID: 5078354
    [No Abstract]   [Full Text] [Related]  

  • 52. [Continued ambulatory therapy of schizophrenic patients using injectable delayed-action neuroleptic drugs].
    Hartmann W; Müller P
    Dtsch Med Wochenschr; 1972 Aug; 97(34):1255-7. PubMed ID: 5048319
    [No Abstract]   [Full Text] [Related]  

  • 53. Phenothiazines and breast cancer.
    Kanhouwa S; Gowdy JM; Solomon JD
    J Natl Med Assoc; 1984 Aug; 76(8):785-8. PubMed ID: 6471116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neuroleptic medication questioned].
    Gunne LM
    Lakartidningen; 1974 Mar; 71(12):1161-2. PubMed ID: 4821495
    [No Abstract]   [Full Text] [Related]  

  • 55. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

  • 57. [The therapeutic risks in the long-term treatment with neuroleptic drugs and lithium. Clinical, histological and biochemical findings].
    Degkwitz R; Consbruch U; Haddenbrock S; Neusch B; Oehlert W; Unsöld R
    Nervenarzt; 1976 Feb; 47(2):81-7. PubMed ID: 815830
    [No Abstract]   [Full Text] [Related]  

  • 58. [Fluspirilene, a new long-term neuroleptic. Clinical experiences from a psychiatric hospital].
    Scheibner H
    Fortschr Med; 1972 Apr; 90(12):482-4. PubMed ID: 4629784
    [No Abstract]   [Full Text] [Related]  

  • 59. [On the problem of the terminal extrapyramidal hyperkineses as observed in 1600 patients during long-term therapy with neuroleptics].
    Degkwitz R; Wenzel W; Binsack KF; Herkert H; Luxenburger O
    Arzneimittelforschung; 1966 Feb; 16(2):276-9. PubMed ID: 4861657
    [No Abstract]   [Full Text] [Related]  

  • 60. Piperacetazine (quide tablets).
    Clin Pharmacol Ther; 1969; 10(5):749-54. PubMed ID: 5808467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.